New Jersey Viral Hepatitis Elimination Summit
Join us for this exciting conference to launch a NJ Statewide Hepatitis Elimination Strategy!
Featuring:
Judith M. Persichilli, R.N., B.S.N., M.A.
Acting Commissioner of New Jersey Department of Health
Carol Jimenez, JD
Deputy Director Strategic Initiatives, Office of HIV/AIDS & Infectious Disease Policy, US Department of Health and Human Services
Carolyn Wester, MD, MPH
Director of the Division of Viral Hepatitis, Centers for Disease Control and Prevention
with:
Lauren Canary, MPH
Director, National Viral Hepatitis Roundtable
Frank A. Ghinassi, PhD, ABPP
President and Chief Executive Officer, Rutgers Health University Behavioral Health Care
Governor James McGreevey
Chairman, New Jersey Reentry Corporation
Tina Tan, MD, MPH
Assistant Commissioner/State Epidemiologist, NJ Department of Health
Navin Tij, MD, MSPH
Physician Scientist and Patient Advocate
Senator Joseph F. Vitale
New Jersey State Senate, Chair of the Committee on Health, Human Services, and Senior Citizens
Su Wang, MD, MPH
Medical Director Center for Asian Health, Cooperman Barnabas Medical Center and President-Elect, World Hepatitis Alliance
Clinical Pre-Session & Breakfast | 8 – 9 am
Topics
>Landscape of national and international policies to eliminate viral hepatitis by 2030
>The state of Hepatitis B & C in New Jersey and confronting the growing epidemic
>The syndemic of the opioid crisis and infectious diseases
>Eliminating health disparities in high risk groups
>Strategies and novel approaches to hepatitis screening, prevention, treatment and cure
Agenda:
> 7:45 am - Registration opens; Breakfast in Resource Room
> 8:00-8:45 am - Clinical Pre-session: Hepatitis B & C 101 & Latest Developments
Dr. Ronald Nahass, ID Care
> 9:00-9:30 am - Welcoming Remarks
Stephen Zieniewicz, President & CEO, Cooperman Barnabas Medical Center
Jen Velez, JD Executive VP, Community & Behavioral Health, RWJBH
Judith Persichilli, RN, Acting Commissioner of Health for NJ
Senator Joseph Vitale, NJ Assemblyman, 19th District
> 9:30-10:30 am - Viral Hepatitis Elimination - National, State, and Patient Perspectives
Moderator: Dr. Su Wang, SBMC, World Hepatitis Alliance
Carol Jimenez, Office of Infectious Disease & HIV/AIDS Policy, HHS
Dr. Tina Tan, NJ State Epidemiologist
Dr. Navin Vij, Physician Scientist & Patient Advocate
> 10:30-10:45 am - Break & Resource Room Open
> 10:45am-12:15 pm - Expert Panel: Hepatitis Syndemics & Micro-Elimination Strategies
Moderator: Chris Menschner, Assistant Commissioner, HIV/STD, TB
Natassia Rosario, Policy and Advocacy, NJ DOH
Governor Jim McGreevey, New Jersey Reentry Corporation
Chari Cohen, Hepatitis B Foundation
Frank Ghinassi, Rutgers Behavioral Health
> 12:15-1 pm - Lunch/Resource Room/Patient Videos
> 1:00-2:00 pm - CDC Strategy & Community Partnerships Supporting Elimination
Moderator: Kyung-Hee Choi, Holy Name Hospital
Dr. Carolyn Wester, Director, Division of Viral Hepatitis, CDC
Lauren Canary, National Viral Hepatitis Roundtable
Annette Gaudino, Treatment Action Group
> 2:00-3:45 pm - Viral Hepatitis Think Tank: Strategy Planning Session
Facilitators: Lauren Canary & Annette Gaudino
Think Tank Session
Attendees will participate in Round Robin format discussion at tables covering 12 different viral hepatitis elimination areas. This will be an exciting and important opportunity to network with colleagues, bring together the hepatitis work that is currently happening in NJ, and plan for future efforts.
Pre-assigned moderators will facilitate the groups to identify target areas, key actions and partnerships for developing and carrying out NJ’s Viral Hepatitis Elimination Strategy.
1.Advocacy & Policy Reform
2.Healthcare-Setting Strategies to Increase Testing
3.Healthcare-Setting Strategies to Increase Care & Treatment
4.Addiction and Opioid Efforts: Increasing Testing & Treatment
5.Harm Reduction & Syringe Services Programs: Increasing Access & Testing
6.Preventing Mother-to-Child Transmission (HBV and HCV)
7.Adult Hepatitis A & B Vaccination Opportunities
8.Reaching Asian, African & Other HBV At-Risk Communities
9.Incarcerated & Reentry Based HCV: Screening & Treatment
10.Integration Opportunities for Testing & Treatment: HIV, Cancer Prevention, Behavioral Health, STD, LGBTQ
11.Data and Surveillance: Reporting, Analysis, Partnerships
12.Mobilizing Patients/Affected Communities & Promoting Health Equity
Make your choice for Think Tank table at http://bit.ly/hepthinktank.
> 3:45-4:00 pm - Next Steps: NJ Hepatitis Coalition Formation, Committees for Strategy
> Closing Remarks: Laura Taylor and Su Wang
Parking:
Please be advised that parking for the event will be available at multiple locations and may be limited depending on your time of arrival:
Parking Lot 7: From Northfield Ave, turn onto East Cedar Street and continue up the hill until you see a blue sign with the #7, turn right. Please note if you are arriving later the lot gate closes at 9:30AM.
RWJBH Corporate: 95 Old Short Hills Rd, West Orange, NJ 07052 (parking may be limited)
Patient Visitor Lot #3: 94 Old Short Hills Rd, Livingston, NJ 07039 (parking is limited)
Shuttle buses are available from both corporate and parking lot #7. The shuttle runs continuously, beginning at 7:00 AM until 9:30AM and from 1:45PM to 8:30PM.
Register Today. Seating is Limited.
or call 888-724-7123